share_log

United States Cellular Analyst Ratings

Benzinga ·  Aug 9, 2023 11:13
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/09/2023 0.26% Wells Fargo $16 → $38 Upgrades Underweight → Equal-Weight
08/08/2023 JP Morgan Upgrades Neutral → Overweight
07/26/2023 -28.76% Morgan Stanley $26 → $27 Maintains Equal-Weight
07/25/2023 -28.76% Morgan Stanley $26 → $27 Maintains Equal-Weight
05/08/2023 -57.78% Wells Fargo $22 → $16 Maintains Underweight
02/07/2023 -36.68% Morgan Stanley $37 → $24 Maintains Equal-Weight
01/10/2023 -47.23% Wells Fargo $33 → $20 Downgrades Overweight → Underweight
11/08/2022 -36.68% JP Morgan $32 → $24 Upgrades Underweight → Neutral
11/07/2022 Raymond James Downgrades Strong Buy → Market Perform
08/08/2022 2.9% Raymond James $41 → $39 Maintains Strong Buy
05/09/2022 8.18% Raymond James $40 → $41 Maintains Strong Buy
04/19/2022 -2.37% Morgan Stanley → $37 Downgrades Overweight → Equal-Weight
02/22/2022 -12.93% Wells Fargo $36 → $33 Maintains Overweight
02/22/2022 5.54% Raymond James $43 → $40 Maintains Strong Buy
08/02/2021 -5.01% JP Morgan $35 → $36 Downgrades Neutral → Underweight
07/22/2021 31.93% Morgan Stanley $50.5 → $50 Maintains Overweight
02/22/2021 -7.65% JP Morgan $42 → $35 Downgrades Overweight → Neutral
01/14/2021 33.25% Morgan Stanley $57 → $50.5 Maintains Overweight
11/16/2020 -5.01% Wells Fargo → $36 Reinstates → Overweight
08/31/2020 21.37% Citigroup $45 → $46 Maintains Buy
08/27/2020 50.4% Morgan Stanley $56 → $57 Maintains Overweight
08/10/2020 13.46% Raymond James $40 → $43 Maintains Strong Buy
07/08/2020 47.76% Morgan Stanley $57 → $56 Maintains Overweight
05/18/2020 5.54% Raymond James $39 → $40 Reiterates → Strong Buy
05/14/2020 -10.29% B. Riley Securities $42 → $34 Maintains Neutral
04/22/2020 2.9% Raymond James $41 → $39 Maintains Strong Buy
04/09/2020 50.4% Morgan Stanley $63 → $57 Maintains Overweight
03/27/2020 10.82% JP Morgan $45 → $42 Maintains Overweight
03/02/2020 66.23% Citigroup $66 → $63 Maintains Buy
11/04/2019 29.29% Raymond James $53 → $49 Upgrades Outperform → Strong Buy
11/04/2019 18.73% JP Morgan → $45 Upgrades Neutral → Overweight
08/06/2019 5.54% Wells Fargo $50 → $40 Maintains Market Perform
08/06/2019 10.82% B. Riley Securities $50 → $42 Maintains Neutral
08/05/2019 21.37% JP Morgan → $46 Upgrades Underweight → Neutral
06/18/2019 70.18% Morgan Stanley $44 → $64.5 Upgrades Equal-Weight → Overweight
05/06/2019 39.84% Raymond James $56 → $53 Reiterates → Outperform
11/06/2018 47.76% Raymond James $43 → $56 Maintains Outperform

What is the target price for United States Cellular (USM)?

The latest price target for United States Cellular (NYSE: USM) was reported by Wells Fargo on August 9, 2023. The analyst firm set a price target for $38.00 expecting USM to rise to within 12 months (a possible 0.26% upside). 9 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for United States Cellular (USM)?

The latest analyst rating for United States Cellular (NYSE: USM) was provided by Wells Fargo, and United States Cellular upgraded their equal-weight rating.

When is the next analyst rating going to be posted or updated for United States Cellular (USM)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of United States Cellular, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for United States Cellular was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

Is the Analyst Rating United States Cellular (USM) correct?

While ratings are subjective and will change, the latest United States Cellular (USM) rating was a upgraded with a price target of $16.00 to $38.00. The current price United States Cellular (USM) is trading at is $37.90, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment